Medication info
Geos Tablet (Acyclovir)

Geos Tablet (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Kooju Pharmaceutical Co., Ltd.
Appearance
Light blue, round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200403056 · Notified 2004.06.22 · Insurance code 669802490

Summary

Main use
Treatment and prevention of herpes simplex; treatment of herpes zoster; treatment of chickenpox in children
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, it is preferable to start when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically stop treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding sleeping hours, for a total of 7 days. 2) In patients with severe immunocompromise or gastrointestinal malabsorption, intravenous administration should be considered. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance below 10 mL/min), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance below 10 mL/min, it is preferable to reduce the dose to 800 mg per dose twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg per dose 3 times daily at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Aged 2 years and older: same as adults. 2) Under 2 years: administer 1/2 the adult dose. 3) Reliable data are not yet available on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is most effective when started as soon as possible after the chickenpox rash appears; administer within 24 hours of rash onset if possible.

Ingredients

Manufacturer
Kooju Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex; treatment of herpes zoster; treatment of chickenpox in children

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of the skin and mucosa
  • shingles virus infection
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent skin and mucosal infections caused by the herpes simplex virus, including primary and recurrent genital herpes. It also effectively alleviates acute pain during the treatment of shingles virus infections. However, its efficacy for postherpetic neuralgia has not yet been clearly demonstrated. Additionally, it is utilized for the treatment of chickenpox in children over 2 years of age. This medication helps in treating various viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, it is preferable to start when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically stop treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding sleeping hours, for a total of 7 days. 2) In patients with severe immunocompromise or gastrointestinal malabsorption, intravenous administration should be considered. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance below 10 mL/min), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance below 10 mL/min, it is preferable to reduce the dose to 800 mg per dose twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg per dose 3 times daily at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Aged 2 years and older: same as adults. 2) Under 2 years: administer 1/2 the adult dose. 3) Reliable data are not yet available on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is most effective when started as soon as possible after the chickenpox rash appears; administer within 24 hours of rash onset if possible.

Precautions

This medication should not be used in patients with known allergies to this drug or its components. Patients with impaired kidney function may experience more prevalent neuropsychiatric side effects, so caution is required. In patients with compromised liver function, the liver function may worsen, requiring careful administration. Special caution should be taken when using this medicine in children, infants, and the elderly. Rarely, serious allergic reactions such as shock or anaphylaxis may occur while using this medication; if symptoms occur, discontinue use immediately and seek appropriate treatment. If signs of hypersensitivity such as rash, fever, blisters, or urticaria appear, discontinue the medication immediately. Symptoms such as hair loss, severe dermatitis, and significant damage to the skin and mucous membranes may also occur. Various neuropsychiatric symptoms such as confusion, hallucinations, seizures, drowsiness, and anxiety may occur, especially in the elderly or in patients with diminished kidney function. Reports of kidney-related side effects like reduced kidney function, hematuria, and proteinuria have also been noted, requiring vigilance. Hematological side effects may include bleeding, anemia, and changes in white blood cell count. Hepatitis, jaundice, and elevated liver function test results may occur as side effects affecting the liver. Gastrointestinal side effects may include nausea, vomiting, abdominal pain, and diarrhea, and if symptoms are severe, the medication should be discontinued. Systemically, symptoms such as fever, muscle weakness, and headache may appear. Arthralgia and myalgia have also been reported. Cardiovascular side effects may include arrhythmias, blood pressure changes, and chest pain. Urinary issues such as dysuria or urinary retention may occur infrequently. If symptoms do not improve or worsen while using this medication, alternative treatments should be considered, especially when administered in the early stages of infection. Patients with compromised immune function should preferably use intravenous forms of this medication. During treatment, sufficient fluid intake is necessary to prevent dehydration and reduce the risk of kidney toxicity. After long-term use, the continuation of this medication should be carefully reviewed. This medication can cause drowsiness or consciousness disturbances, so care should be taken when driving or operating hazardous machinery. There may be interactions with other medications, especially with those affecting kidney function, necessitating careful use when combined with such drugs. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and it is safer to discontinue use during breastfeeding. Children and neonates should exercise extra caution when using this medicine, and the elderly may require dosage adjustments due to increased drug concentrations from impaired kidney function.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 117 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration disturbance
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • memory loss
  • insomnia
  • anxiety
  • talking to oneself
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • appetite loss
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • lethargy
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • lowered blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • gustatory disturbance
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is best to store it at room temperature between 1 degree and 30 degrees.

Appearance and packaging

Appearance

Light blue, round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.